Effect of Daily Music Listening on Stroke Recovery (MUKU2)
Primary Purpose
Stroke
Status
Completed
Phase
Not Applicable
Locations
Finland
Study Type
Interventional
Intervention
Music listening
Audiobook listening
Sponsored by

About this trial
This is an interventional treatment trial for Stroke focused on measuring Stroke, Recovery, Music
Eligibility Criteria
Inclusion Criteria:
- Acute Hemispheral stroke
Exclusion Criteria:
- Previous neurological or current psychiatric disease,
- severe aphasia
Sites / Locations
- Turku University Hospital
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm Type
Experimental
Experimental
Active Comparator
Arm Label
Instrumental music listening
Vocal music listening
Audiobook listening (control)
Arm Description
Daily music listening
Daily music listening
Daily audiobook listening
Outcomes
Primary Outcome Measures
Change in neuropsychological performance (verbal memory)
Verbal memory summary score (Rivermead Behavioral Memory Test (RBMT) story recall, auditory-verbal learning task)
Change in neuropsychological performance (verbal memory)
Verbal memory summary score (RBMT story recall, auditory-verbal learning task)
Secondary Outcome Measures
Change in neuropsychological performance (Language skill)
Verbal fluency task
Change in neuropsychological performance (Language skill)
Naming test CERAD/Boston Naming Test (BNT)
Change in neuropsychological performance (Language skill)
Short Token Test
Change in neuropsychological performance (Language skill)
Verbal fluency task
Change in neuropsychological performance (Language skill)
Naming test CERAD/BNT
Change in neuropsychological performance (Language skill)
Short Token Test
Change in mood
Profile of Mood States
Change in mood
Profile of Mood States
Change in structural gray matter
Voxel-based morphometry
Change in structural gray matter changes
Voxel-based morphometry
Change in structural white matter
Diffusion-weighted imaging
Change in structural white matter
Diffusion-weighted imaging
Change in neuronal function
Resting state/task-based fMRI
Change in neuronal function
Resting state/task-based fMRI
Change in physiological stress level
Cortisol serum concentration
Change in physiological stress level
Cortisol serum concentration
Change in physiological stress level
Beta-endorphin serum concentration
Change in physiological stress level
Beta-endorphin serum concentration
Change in physiological stress level
Oxytocin serum concentration
Change in physiological stress level
Oxytocin serum concentration
Full Information
NCT ID
NCT01749709
First Posted
December 12, 2012
Last Updated
December 31, 2021
Sponsor
Turku University Hospital
Collaborators
Academy of Finland
1. Study Identification
Unique Protocol Identification Number
NCT01749709
Brief Title
Effect of Daily Music Listening on Stroke Recovery
Acronym
MUKU2
Official Title
Effect of Cognitive Stimulation on Recovery After Stroke
Study Type
Interventional
2. Study Status
Record Verification Date
December 2021
Overall Recruitment Status
Completed
Study Start Date
December 2012 (undefined)
Primary Completion Date
April 5, 2016 (Actual)
Study Completion Date
April 5, 2016 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Turku University Hospital
Collaborators
Academy of Finland
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Single blind randomized clinical trial including 50 stroke patients to investigate the effect of daily music listening on behavioral, neural and physiological recovery. Patients are randomized (1:1:1) to listen instrumental or vocal music, or audiobooks (recorded book reading) (control). Outcome measures are change in neuropsychological tests, change in self-reported mood, structural and functional magnetic resonance imaging changes and hormonal changes performed at acute, 3-month and 6-month stages.
Detailed Description
Please see above
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Stroke
Keywords
Stroke, Recovery, Music
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Factorial Assignment
Masking
InvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
50 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Instrumental music listening
Arm Type
Experimental
Arm Description
Daily music listening
Arm Title
Vocal music listening
Arm Type
Experimental
Arm Description
Daily music listening
Arm Title
Audiobook listening (control)
Arm Type
Active Comparator
Arm Description
Daily audiobook listening
Intervention Type
Behavioral
Intervention Name(s)
Music listening
Intervention Type
Behavioral
Intervention Name(s)
Audiobook listening
Primary Outcome Measure Information:
Title
Change in neuropsychological performance (verbal memory)
Description
Verbal memory summary score (Rivermead Behavioral Memory Test (RBMT) story recall, auditory-verbal learning task)
Time Frame
From acute to 3-month-stage
Title
Change in neuropsychological performance (verbal memory)
Description
Verbal memory summary score (RBMT story recall, auditory-verbal learning task)
Time Frame
From acute to 6-month-stage
Secondary Outcome Measure Information:
Title
Change in neuropsychological performance (Language skill)
Description
Verbal fluency task
Time Frame
From acute to 3-month-stage
Title
Change in neuropsychological performance (Language skill)
Description
Naming test CERAD/Boston Naming Test (BNT)
Time Frame
From acute to 3-month-stage
Title
Change in neuropsychological performance (Language skill)
Description
Short Token Test
Time Frame
From acute to 3-month-stage
Title
Change in neuropsychological performance (Language skill)
Description
Verbal fluency task
Time Frame
From acute to 6-month-stages
Title
Change in neuropsychological performance (Language skill)
Description
Naming test CERAD/BNT
Time Frame
From acute to 6-month-stages
Title
Change in neuropsychological performance (Language skill)
Description
Short Token Test
Time Frame
From acute to 6-month-stages
Title
Change in mood
Description
Profile of Mood States
Time Frame
From acute to 3-month-stage
Title
Change in mood
Description
Profile of Mood States
Time Frame
From acute to 6-month-stage
Title
Change in structural gray matter
Description
Voxel-based morphometry
Time Frame
From acute to 3-month-stage
Title
Change in structural gray matter changes
Description
Voxel-based morphometry
Time Frame
From acute to 6-month-stage
Title
Change in structural white matter
Description
Diffusion-weighted imaging
Time Frame
From acute to 3-month stage
Title
Change in structural white matter
Description
Diffusion-weighted imaging
Time Frame
From acute to 6-month stage
Title
Change in neuronal function
Description
Resting state/task-based fMRI
Time Frame
From acute to 3-month stage
Title
Change in neuronal function
Description
Resting state/task-based fMRI
Time Frame
From acute to 6-month stage
Title
Change in physiological stress level
Description
Cortisol serum concentration
Time Frame
From acute to 3-month-stage
Title
Change in physiological stress level
Description
Cortisol serum concentration
Time Frame
From acute to 6-month-stage
Title
Change in physiological stress level
Description
Beta-endorphin serum concentration
Time Frame
From acute to 3-month-stage
Title
Change in physiological stress level
Description
Beta-endorphin serum concentration
Time Frame
From acute to 6-month-stage
Title
Change in physiological stress level
Description
Oxytocin serum concentration
Time Frame
From acute to 3-month-stage
Title
Change in physiological stress level
Description
Oxytocin serum concentration
Time Frame
From acute to 6-month-stage
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Acute Hemispheral stroke
Exclusion Criteria:
Previous neurological or current psychiatric disease,
severe aphasia
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Valtteri Kaasinen, MD
Organizational Affiliation
Department of Clinical Neurosciences
Official's Role
Study Chair
Facility Information:
Facility Name
Turku University Hospital
City
Turku
Country
Finland
12. IPD Sharing Statement
Learn more about this trial
Effect of Daily Music Listening on Stroke Recovery
We'll reach out to this number within 24 hrs